Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Matter; Hans
Address:
Langenselbold, DE
No. of patents:
23
Patents:




Patent Number Title Of Patent Date Issued
7507734 Pyridazinone derivatives March 24, 2009
Disclosed are compounds according to the general formula (I), where the definitions of the substituents X, R.sup.1 and R.sup.2 are detailed in the description, as well as their physiologically acceptable salts and solvate, methods for producing these compounds and their use as pharma
7470689 4-benzimidazol-2-ylpyridazin-3-one derivatives December 30, 2008
Disclosed are compounds of the general formula (I), where the definition of the substituents A, B, D, E, R.sup.1 and R.sup.2 are detailed in the description, and the physiologically tolerated salts thereof, a process for the preparation of these compounds and their use as pharmaceuticals
7465806 Pyrrole-derivatives as factor Xa inhibitors December 16, 2008
The present invention relates to compounds of the formulae I and Ia, ##STR00001## wherein R.sup.0; R.sup.1; R3; R4; R22, Q; V, G and M have the meanings indicated in the claims. The compounds of the formulae I and Ia are valuable pharmacologically active compounds. They exhibit a strong
7462613 Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them December 9, 2008
The present invention relates to novel pyridazinone derivatives of the general formula (I) ##STR00001## wherein A is A1 or A2; ##STR00002## R is unsubstituted or at least monosubstituted C.sub.1-C.sub.10-alkyl, aryl, aryl-(C.sub.1-C.sub.10-alkyl)-, heteroaryl, heteroaryl-(C.sub.1-C
7435747 Guanidine and amidine derivatives as factor Xa inhibitors October 14, 2008
The present invention relates to compounds of the formula I, ##STR00001## in which R.sub.0; Q; X; Q', D, R.sub.10 and V have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effe
7429581 Pyrazole-derivatives as factor Xa inhibitors September 30, 2008
The present invention is directed to a compound of formula I, ##STR00001## in which R.sup.0; R.sup.1; R.sup.2; R.sup.3; R.sup.4; Q; V, G and M have the meanings indicated below. The compound of formula I is a pharmacologically active compound. It exhibits a strong anti-thrombotic ef
7399770 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors July 15, 2008
The invention is directed to a compound of the formula I ##STR00001## wherein the variables are as defined herein, or a stereoisomeric form thereof, mixture of stereoisomeric forms, in any ratio, or a salt thereof.Another aspect of the present invention is directed to a pharmaceutica
7365088 Indazole-derivatives as factor Xa inhibitors April 29, 2008
The present invention relates to a compound of the formula I ##STR00001## wherein J.sub.1, J.sub.2, R.sup.0, R.sup.1, R.sup.2, Q, V, G and M are as defined herein. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic eff
7358268 Imidazole derivatives as factor Xa inhibitors April 15, 2008
This invention is directed to the compound of formula (I) which is useful for inhibiting the activity of Factor Xa. The present invention is also directed to compositions containing said compounds, processes for their preparation, their use, such as in inhibiting the formation of thrombi
7317027 Azaindole-derivatives as factor Xa inhibitors January 8, 2008
The present invention relates to compounds of the formula I ##STR00001## wherein R.sup.0, R.sup.1, R.sup.2, R.sup.3, Q, V, G and M are as defined herein. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are
7309701 Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them December 18, 2007
The present invention relates to novel pyridazinone derivatives of the general formula (I) ##STR00001## wherein A is A1 or A2; ##STR00002## R is unsubstituted or at least monosubstituted C.sub.1-C.sub.10-alkyl, aryl, aryl-(C.sub.1-C.sub.10-alkyl)-, heteroaryl, heteroaryl-(C.s
7205315 Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases April 17, 2007
The present invention is directed to a compound of formula (I), or a stereoisomer or a mixture of stereoisomer thereof in any ratio, or its physiologically tolerable salt, which is useful as an inhibitor of matrix metalloproteinase. The present invention is also directed to a pharmac
7153876 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and t December 26, 2006
Compounds of formula I, ##STR00001## in which R.sup.1, R.sup.2, A, and B having the definitions set forth in the claims, are valuable pharmacologically active compounds, which exhibit a strong antithrombotic effect and are suitable, for example, for treating thromboembolic diseases
7067665 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla June 27, 2006
The present invention relates to compounds comprising the following formula: R.sup.0-Q-X-Q'-W-U-V-G-M (I) These compounds are useful as pharmacologically active compounds. They exhibit an antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiov
6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia October 11, 2005
The present invention relates to compounds comprising the following formula:These compounds are useful as pharmacologically active compounds. They exhibit an antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders such as thromboem
6906084 Indole derivatives as factor Xa inhibitors June 14, 2005
The present invention relates to compounds of formula I, ##STR1##in which R.sup.0 ; R.sup.1 ; R.sup.2 ; R.sup.3 ; R.sup.4 ; R.sup.5 ; R.sup.6 ; R.sup.7 ; Q; V, G and M have the meanings indicated in the claims. The compounds of formula I are valuable pharmacologically active compound
6759420 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical composit July 6, 2004
The present invention is directed to new compounds for the inhibition of blood clotting proteins and factor Xa activity, and more particularly, to arylalkanoyl derivatives of the formula (I): ##STR1##wherein R(1), R(2), R(3), R(4), R(5), R(6a), and R(6b) have the meanings indicated i
6743790 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use June 1, 2004
The present invention relates to compounds of the formula I, ##STR1##in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, A, X, m and n have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a stro
6706715 Urea derivatives with antiproteolytic activity March 16, 2004
The present invention relates to compounds of the formula I, ##STR1##in which R.sup.1, R.sup.2, R.sup.4, R.sup.5, D.sub.1, D.sub.2, X.sub.1, X.sub.2, X.sub.3, A and B have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compo
6645992 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and t November 11, 2003
Compounds of formula I, ##STR1##in which R.sup.1, R.sup.2, A, and B having the definitions set forth in the claims, are valuable pharmacologically active compounds, which exhibit a strong antithrombotic effect and are suitable, for example, for treating thromboembolic diseases and re
6500803 Factor VIIa inhibitors December 31, 2002
The present invention relates to compounds of formula I, ##STR1##in which R.sup.1, R.sup.2, R.sup.91, R.sup.92, R.sup.93, R.sup.94, R.sup.95, R.sup.96, R.sup.97, r, s, and t have the meanings indicated in the claims. Compounds of formula I are valuable pharmacologically active compou
6395737 Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical comp May 28, 2002
New compounds for the inhibition of blood clotting proteins, and more particularly, to malonic acid derivatives of the formula I, ##STR1##wherein R(1), R(2), R(3), R(4), R(5), and R(6) have the meanings indicated in the claims. The compounds of formula I are inhibitors of the blood c
6337344 Indole derivatives as inhibitors or factor Xa January 8, 2002
The present invention relates to the inhibition of blood clotting proteins, and more particularly, to indole derivatives of formula (I), in which R.sup.1a, R.sup.1b, R.sup.1c R.sup.1d, R.sup.2, R.sup.3, R.sup.4 and A are defined as indicated in the claims. The compounds of formula (I) ar


 
 
  Recently Added Patents
Fusion protein of human IgG1 heavy chain constant region and scFv antibody against equine encephalitis virus
Machine-implemented activity management system using asynchronously shared activity data objects and journal data items
Spectroscopic polarimetry
Movable contact, sheet having movable contact, and switch apparatus using the same
Valve timing controller
Speech recognition method computer readable medium and apparatus for recognizing geographical names using weight information
Abstract records
  Randomly Featured Patents
Gauge
Detergent bars with improved slip properties
Communication system including method and apparatus for maintaining communications with a mobile terminal
Silk hat shaped wave gear device
One piece double shell box with closure fastener
Side wing for a motorcycle front cowl
Wavelength selective switch and equalizer
Knock-down fireplace grate
Pre-cast security vault
Energy absorbing composite tube